(Q53198094)

English

Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women.

scientific article published on 8 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Richard Eastell

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

M L Frost

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Siddique

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

G M Blake

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

A E Moore

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

P K Marsden

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

P J Schleyer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

I Fogelman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

0 references

publication date

8 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Osteoporosis International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

2107-2116

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

https://scigraph.springernature.com/pub.10.1007/s00198-011-1805-9

0 references

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Ten years' experience with alendronate for osteoporosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Seven years of treatment with risedronate in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Differences between bisphosphonates in binding affinities for hydroxyapatite.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Bisphosphonates for post-menopausal osteoporosis: are they all the same?

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Bisphosphonates: from bench to bedside

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Bone safety of long-term bisphosphonate treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Fracture risk remains reduced one year after discontinuation of risedronate

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

The relationship between regional bone turnover measured using 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Establishing a reference range for bone turnover markers in young, healthy women

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

How long should patients take medications for postmenopausal osteoporosis?

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Risks and benefits of long-term bisphosphonate therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Osteoporosis: how long should we treat?

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Comparison of Weekly Treatment of Postmenopausal Osteoporosis with AlendronateVersusRisedronate Over Two Years

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1805-9

21 January 2018

Differences in regional bone perfusion and turnover between lumbar spine and distal humerus: (18)F-fluoride PET study of treatment-naïve and treated postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased sensitivity in detection of a porcine high-turnover osteopenia after total gastrectomy by dynamic 18F-fluoride ion PET and quantitative CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of comparative effectiveness of treatments to prevent fractures

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of porcine bone metabolism by dynamic.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(18)F-fluoride PET for monitoring therapeutic response in Paget's disease of bone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid and robust response of biochemical markers of bone formation to teriparatide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of low femoral bone density in older U.S. women from NHANES III

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of skeletal kinetic indices in Paget's disease using dynamic 18F-fluoride positron emission tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of teriparatide on regional bone formation using (18)F-fluoride positron emission tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/21983795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00198-011-1805-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21983795%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53198094&oldid=1551248152"